The ability of TLR2 polymorphisms to influence the intensity of the inflammatory response is particularly important in diseases characterized by chronic inflammation, such as chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, and diabetes [91,94,95]. This evidence concerns the gene TLR2 and chronic obstructive pulmonary disease.